Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 13 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (3)
P 1 (2)
P 2 (2)
P 3 (1)
P 4 (1)

Trial Status

Completed7
Unknown2
Recruiting2
Active Not Recruiting1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT05989646Not ApplicableRecruiting

Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children

NCT07535619Recruiting

The Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents - the PpUF-study.

NCT04114266Active Not Recruiting

Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD

NCT03325543Not ApplicableCompleted

Can Women Correctly Contract Their Pelvic Floor Muscles After to Receive Verbal Instructions and Vaginal Palpation?

NCT07067957Not Yet Recruiting

Prevalence of Functional Lower Urinary Tract Voiding Dysfunction in School-Aged Children

NCT02291432Phase 1Completed

Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery

NCT00214045Not ApplicableCompleted

Rigid Versus Flexible Cystoscopy in Women

NCT02266524Phase 1CompletedPrimary

Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders

NCT02130843CompletedPrimary

Tiemann Mounted Urodynamic Catheter Technique for Difficult Bladder Catheterization

NCT01833663Phase 4Completed

Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women

NCT01760096Phase 2Unknown

Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)

NCT01642979Phase 2Unknown

Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria

NCT00338624Phase 3CompletedPrimary

An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.

Showing all 13 trials

Research Network

Activity Timeline